Mergers and Acquisitions TRANSACTIONAL

We have decades of experience advising public and private companies in all aspects of mergers and acquisitions in both the US and Europe. In 2012, we advised clients throughout the United States and Europe on more than 100 M&A transactions with an aggregate value in excess of $15 billion, providing guidance in areas including corporate, securities, antitrust and tax. Since 2005, we have participated in more than 850 mergers and acquisitions valued in excess of $300 billion, ranging from sales of VC-backed companies to multibillion-dollar global mergers. Our experience ranges from public-public mergers and the related SEC, disclosure and fiduciary duty issues to the unique issues presented by sales of VC-backed private companies. We also advise clients on friendly and hostile tender offers, and represent investment banks serving as financial advisors in mergers. Our recent M&A transactions include:

  • EqualLogic's acquisition by Dell for $1.4 billion
  • Kronos' acquisition by Hellman & Friedman for $1.8 billion
  • Danaher's acquisition of Tektronix for $2.8 billion
  • PerkinElmer's acquisition of ViaCell for $300 million
  • Akamai Technologies' acquisition of Speedera Networks for $130 million in stock
  • Avid’s acquisition of Pinnacle Systems for $462 million in stock and cash
  • CMGI’s sale of AltaVista for $140 million in cash and stock
  • Netegrity’s acquisition by Computer Associates for $430 million in cash
  • Raytheon’s sale of its aircraft modification and integration business to L-3 Communications for $1.1 billion in cash
  • Transkaryotic Therapies' acquisition by Shire Pharmaceuticals for $1.6 billion in cash
  • Verizon Wireless’ acquisition of Spectrum Assets from NextWave Telecom for $930 million in cash

Additional M&A experience: 20132012, 2011, 2010, 2009, 2008, 2007, 2006, 2005, 2004, 2003, 2002, 2001, 2000, 1999

Leadership

Sort By
Bothwick, Jay E.

Jay E. Bothwick

Co-Chair, Mergers and Acquisitions Practice Group

+1 617 526 6526 (t)

jay.bothwick@wilmerhale.com

Leibowitz, Hal J.

Hal J. Leibowitz

Co-Chair, Mergers and Acquisitions Practice Group

+1 617 526 6461 (t)

hal.leibowitz@wilmerhale.com

White, Thomas W.

Thomas W. White

General Counsel

+1 202 663 6556 (t)

thomas.white@wilmerhale.com

Bain, Mick

Mick Bain

Partner

+1 781 966 2027 (t)

michael.bain@wilmerhale.com

Boot, Jeannette K.

Jeannette K. Boot

Partner

+1 212 295 6507 (t)

jeannette.boot@wilmerhale.com

Borden, Mark G.

Mark G. Borden

Partner

+1 617 526 6675 (t)

mark.borden@wilmerhale.com

Bothwick, Jay E.

Jay E. Bothwick

Partner

+1 617 526 6526 (t)

jay.bothwick@wilmerhale.com

Braun, Martin

Dr. Martin Braun

Partner

+49 69 27 10 78 207 (t)

martin.braun@wilmerhale.com

Brown, Lillian

Lillian Brown

Partner

+1 202 663 6743 (t)

lillian.brown@wilmerhale.com

Buckland, Peter

Peter Buckland

Partner

+1 650 858 6036 (t)

peter.buckland@wilmerhale.com

Publications & News

View

May 20, 2013

Legal 500 EMEA 2013 Recognizes WilmerHale Attorneys, Practices

The 2013 edition of The Legal 500 Europe, Middle East and Africa has been released, and includes recognition for 10 WilmerHale practice areas and 13 individual lawyers.

May 6, 2013

2013 M&A Report

Our 2013 M&A Report offers a detailed review of, and outlook for, the global M&A market. Other highlights include a discussion of the challenges and benefits of selling your company in a “dual-track” IPO, a comparison of public and private acquisitions, an analysis of issues and opportunities in California M&A deals, and a review of takeover defenses adopted by public companies. It also takes a look at the facts of life in M&A deal litigation, and survey key terms  in sales of VC-backed companies.

May 6, 2013

2013 Corporate Reports

WilmerHale’s annual IPO, Venture Capital and M&A Reports provide comprehensive statistics and analysis that are hard to find elsewhere.

April 17, 2013

Selected 2013 Life Sciences Transactions

Recognized both globally and nationally as a leading life sciences practice, WilmerHale has four decades of experience representing biotechnology, pharmaceutical and medical device companies at all stages of growth, as well as venture capitalists and investment banks.

March 14, 2013

WilmerHale Earns Top Rankings in BioPharm Insight’s 2012 League Tables

BioPharm Insight’s 2012 Licensing League Tables ranks WilmerHale as the leading legal advisor in its global and North America volume tables and lists the firm in fourth place in its global and North America value tables.

March 4, 2013

WilmerHale Lawyers, Practice Recognized by Chambers Asia Pacific 2013

Chambers Asia Pacific has released its 2013 rankings, which include the recognition of two WilmerHale lawyers as well as the China Corporate Practice. Chambers Asia Pacific acknowledges Lester Ross for his Corporate/M&A: China-based (International Firms) practice and Tao Xu for her Corporate/M&A: China-based (International Firms) practice in the 2013 edition of this guide to leading lawyers and law firms in Asia.

February 20, 2013

Selected 2013 M&A Transactions

In 2012, we advised clients throughout the United States and Europe on more than 100 M&A transactions with an aggregate value of approximately $15 billion, providing guidance in areas including corporate, securities, antitrust and tax.

January 28, 2013

Chinese Government Plans Consolidation of Domestic Industry

January 7, 2013

Starting a Company? Don't Succumb to These Three Common Legal Issues

An article by Jennifer Berrent, published by VentureBeat.

December 11, 2012

JUVE Once Again Ranks WilmerHale Among "Top 50" Law Firms in Germany